{"count": 36, "results": [{"_id": "36348831", "pmid": 36348831, "pmcid": "PMC9629747", "title": "Renal Effects of High-Dose Versus Low-Dose Lisinopril in Patients With Diabetic Nephropathy", "journal": "Cureus", "authors": ["Rashid FR", "Abubakar M", "Fayyaz H", "Umer N", "Shafiq A", "Sajjad W", "Rashid K", "Ellahi A"], "date": "2022-10-03T00:00:00Z", "doi": "10.7759/cureus.29873", "meta_date_publication": "2022 Oct", "meta_volume": "14", "meta_issue": "10", "meta_pages": "e29873", "score": 50310.51, "text_hl": "Renal Effects of High-Dose Versus Low-Dose @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ in @SPECIES_9606 @@@Patients@@@ With @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@Diabetic Nephropathy@@@", "citations": {"NLM": "Rashid FR, Abubakar M, Fayyaz H, Umer N, Shafiq A, Sajjad W, Rashid K, Ellahi A. Renal Effects of High-Dose Versus Low-Dose Lisinopril in Patients With Diabetic Nephropathy Cureus. 2022 Oct;14(10):e29873. PMID: 36348831", "BibTeX": "@article{36348831, title={Renal Effects of High-Dose Versus Low-Dose Lisinopril in Patients With Diabetic Nephropathy}, author={Rashid FR and Abubakar M and Fayyaz H and Umer N and Shafiq A and Sajjad W and Rashid K and Ellahi A}, journal={Cureus}, volume={14}, number={10}, pages={e29873}}"}}, {"_id": "35884965", "pmid": 35884965, "pmcid": "PMC9313388", "title": "Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease", "journal": "Biomedicines", "authors": ["Dalbøge LS", "Christensen M", "Madsen MR", "Secher T", "Endlich N", "Drenic' V", "Manresa-Arraut A", "Hansen HH", "Rune I", "Fink LN", "Østergaard MV"], "date": "2022-07-11T00:00:00Z", "doi": "10.3390/biomedicines10071661", "meta_date_publication": "2022 Jul 11", "meta_volume": "10", "meta_issue": "7", "meta_pages": "", "score": 50281.77, "text_hl": "Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ in a @SPECIES_10090 @@@Mouse@@@ Model of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertension@@@-Accelerated @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@Diabetic Kidney Disease@@@", "citations": {"NLM": "Dalbøge LS, Christensen M, Madsen MR, Secher T, Endlich N, Drenic' V, Manresa-Arraut A, Hansen HH, Rune I, Fink LN, Østergaard MV. Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease Biomedicines. 2022 Jul 11;10(7):. PMID: 35884965", "BibTeX": "@article{35884965, title={Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease}, author={Dalbøge LS and Christensen M and Madsen MR and Secher T and Endlich N and Drenic' V and Manresa-Arraut A and Hansen HH and Rune I and Fink LN and Østergaard MV}, journal={Biomedicines}, volume={10}, number={7}}"}}, {"_id": "32665926", "pmid": 32665926, "pmcid": "PMC7350971", "title": "Lisinopril-Induced Liver Injury: An Unusual Presentation and Literature Review", "journal": "Eur J Case Rep Intern Med", "authors": ["Al-Rifaie A", "Khan MA", "Ali A", "Dube AK", "Gleeson D", "Hoeroldt B"], "date": "2020-04-15T00:00:00Z", "doi": "10.12890/2020_001600", "meta_date_publication": "2020", "meta_volume": "7", "meta_issue": "7", "meta_pages": "001600", "score": 50272.246, "text_hl": "She had been started on @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ for @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@ 8 weeks before admission. ", "citations": {"NLM": "Al-Rifaie A, Khan MA, Ali A, Dube AK, Gleeson D, Hoeroldt B. Lisinopril-Induced Liver Injury: An Unusual Presentation and Literature Review Eur J Case Rep Intern Med. 2020;7(7):001600. PMID: 32665926", "BibTeX": "@article{32665926, title={Lisinopril-Induced Liver Injury: An Unusual Presentation and Literature Review}, author={Al-Rifaie A and Khan MA and Ali A and Dube AK and Gleeson D and Hoeroldt B}, journal={Eur J Case Rep Intern Med}, volume={7}, number={7}, pages={001600}}"}}, {"_id": "34180715", "pmid": 34180715, "title": "Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease.", "journal": "Am J Physiol Renal Physiol", "authors": ["Østergaard MV", "Secher T", "Christensen M", "Salinas CG", "Roostalu U", "Skytte JL", "Rune I", "Hansen HH", "Jelsing J", "Vrang N", "Fink LN"], "date": "2021-08-01T00:00:00Z", "doi": "10.1152/ajprenal.00154.2021", "meta_date_publication": "2021 Aug 1", "meta_volume": "321", "meta_issue": "2", "meta_pages": "F149-F161", "score": 50268.03, "text_hl": "Therapeutic effects of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_empagliflozin @CHEMICAL_MESH:C570240 @@@empagliflozin@@@ in a @SPECIES_10090 @@@mouse@@@ model of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@-accelerated @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@diabetic kidney disease@@@.", "citations": {"NLM": "Østergaard MV, Secher T, Christensen M, Salinas CG, Roostalu U, Skytte JL, Rune I, Hansen HH, Jelsing J, Vrang N, Fink LN. Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease. Am J Physiol Renal Physiol. 2021 Aug 1;321(2):F149-F161. PMID: 34180715", "BibTeX": "@article{34180715, title={Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease.}, author={Østergaard MV and Secher T and Christensen M and Salinas CG and Roostalu U and Skytte JL and Rune I and Hansen HH and Jelsing J and Vrang N and Fink LN}, journal={Am J Physiol Renal Physiol}, volume={321}, number={2}, pages={F149-F161}}"}}, {"_id": "32416710", "pmid": 32416710, "title": "Combination of Naringenin and Lisinopril Ameliorates Nephropathy in Type-1 Diabetic Rats.", "journal": "Endocr Metab Immune Disord Drug Targets", "authors": ["Kulkarni YA", "Suryavanshi SV"], "date": "2021-01-01T00:00:00Z", "doi": "10.2174/1871530320666200516163919", "meta_date_publication": "2021", "meta_volume": "21", "meta_issue": "1", "meta_pages": "173-182", "score": 50265.785, "text_hl": "OBJECTIVE: The objective of the present study was to evaluate the effect of a combination of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ with @CHEMICAL_naringenin @CHEMICAL_MESH:C005273 @@@naringenin@@@ in @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@. ", "citations": {"NLM": "Kulkarni YA, Suryavanshi SV. Combination of Naringenin and Lisinopril Ameliorates Nephropathy in Type-1 Diabetic Rats. Endocr Metab Immune Disord Drug Targets. 2021;21(1):173-182. PMID: 32416710", "BibTeX": "@article{32416710, title={Combination of Naringenin and Lisinopril Ameliorates Nephropathy in Type-1 Diabetic Rats.}, author={Kulkarni YA and Suryavanshi SV}, journal={Endocr Metab Immune Disord Drug Targets}, volume={21}, number={1}, pages={173-182}}"}}, {"_id": "34282598", "pmid": 34282598, "title": "Effect of Lisinopril and Verapamil on Angiopoietin 2 and Endostatin in Hypertensive Diabetic Patients with Nephropathy: A Randomized Trial.", "journal": "Horm Metab Res", "authors": ["Salem M", "Sallam AM", "Abdel-Aleem E", "El-Mesallamy HO"], "date": "2021-07-01T00:00:00Z", "doi": "10.1055/a-1517-6643", "meta_date_publication": "2021 Jul", "meta_volume": "53", "meta_issue": "7", "meta_pages": "470-477", "score": 50259.883, "text_hl": "Angiotensin-converting enzyme inhibitors (ACEI) and calcium channel blockers (CCB) have an important role in @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@DN@@@. We performed a randomized-controlled trial of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ alone (an ACEI) or in combination with @CHEMICAL_Verapamil @CHEMICAL_MESH:D014700 @@@verapamil@@@ (a CCB) as a therapy for @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@DN@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ (@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@) @SPECIES_9606 @@@patients@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ (@DISEASE_Hypertension @DISEASE_MESH:D006973 @@@HTN@@@) and urinary @GENE_ALB @GENE_213 @@@albumin@@@ @CHEMICAL_Creatinine @CHEMICAL_MESH:D003404 @@@creatinine@@@ ratio (UACR) (30-300 mg/g) also to evaluate their effect on UACR, the angiogenic proteins: @GENE_ANGPT2 @GENE_285 @@@Angiopoietin 2@@@ (@GENE_ANGPT2 @GENE_285 @@@Ang-2@@@) and @GENE_COL18A1 @GENE_80781 @@@Endostatin@@@ (@GENE_COL18A1 @GENE_80781 @@@EST@@@). ", "citations": {"NLM": "Salem M, Sallam AM, Abdel-Aleem E, El-Mesallamy HO. Effect of Lisinopril and Verapamil on Angiopoietin 2 and Endostatin in Hypertensive Diabetic Patients with Nephropathy: A Randomized Trial. Horm Metab Res. 2021 Jul;53(7):470-477. PMID: 34282598", "BibTeX": "@article{34282598, title={Effect of Lisinopril and Verapamil on Angiopoietin 2 and Endostatin in Hypertensive Diabetic Patients with Nephropathy: A Randomized Trial.}, author={Salem M and Sallam AM and Abdel-Aleem E and El-Mesallamy HO}, journal={Horm Metab Res}, volume={53}, number={7}, pages={470-477}}"}}, {"_id": "34219205", "pmid": 34219205, "title": "Renin-angiotensin system inhibition reverses the altered triacylglycerol metabolic network in diabetic kidney disease.", "journal": "Metabolomics", "authors": ["Sas KM", "Lin J", "Wang CH", "Zhang H", "Saha J", "Rajendiran TM", "Soni T", "Nair V", "Eichinger F", "Kretzler M", "Brosius FC 3rd", "Michailidis G", "Pennathur S"], "date": "2021-07-04T00:00:00Z", "doi": "10.1007/s11306-021-01816-0", "meta_date_publication": "2021 Jul 4", "meta_volume": "17", "meta_issue": "7", "meta_pages": "65", "score": 50252.98, "text_hl": "A subset of @SPECIES_10090 @@@mice@@@ were treated with the renin-angiotensin system (RAS) inhibitors, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@, which improves the @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@DKD@@@ phenotype in the db/db @GENE_NOS3 @GENE_18127 @@@eNOS@@@-/- @SPECIES_10090 @@@mouse@@@ model. ", "citations": {"NLM": "Sas KM, Lin J, Wang CH, Zhang H, Saha J, Rajendiran TM, Soni T, Nair V, Eichinger F, Kretzler M, Brosius FC 3rd, Michailidis G, Pennathur S. Renin-angiotensin system inhibition reverses the altered triacylglycerol metabolic network in diabetic kidney disease. Metabolomics. 2021 Jul 4;17(7):65. PMID: 34219205", "BibTeX": "@article{34219205, title={Renin-angiotensin system inhibition reverses the altered triacylglycerol metabolic network in diabetic kidney disease.}, author={Sas KM and Lin J and Wang CH and Zhang H and Saha J and Rajendiran TM and Soni T and Nair V and Eichinger F and Kretzler M and Brosius FC 3rd and Michailidis G and Pennathur S}, journal={Metabolomics}, volume={17}, number={7}, pages={65}}"}}, {"_id": "10097934", "pmid": 10097934, "title": "Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.", "journal": "Diabetes Care", "authors": ["Tarnow L", "Sato A", "Ali S", "Rossing P", "Nielsen FS", "Parving HH"], "date": "1999-03-01T00:00:00Z", "doi": "10.2337/diacare.22.3.491", "meta_date_publication": "1999 Mar", "meta_volume": "22", "meta_issue": "3", "meta_pages": "491-4", "score": 50077.5, "text_hl": "Effects of @CHEMICAL_Nisoldipine @CHEMICAL_MESH:D015737 @@@nisoldipine@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on left ventricular mass and function in @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@.", "citations": {"NLM": "Tarnow L, Sato A, Ali S, Rossing P, Nielsen FS, Parving HH. Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy. Diabetes Care. 1999 Mar;22(3):491-4. PMID: 10097934", "BibTeX": "@article{10097934, title={Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.}, author={Tarnow L and Sato A and Ali S and Rossing P and Nielsen FS and Parving HH}, journal={Diabetes Care}, volume={22}, number={3}, pages={491-4}}"}}, {"_id": "11328901", "pmid": 11328901, "title": "Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies.", "journal": "Nephrol Dial Transplant", "authors": ["Cinotti GA", "Zucchelli PC", "Collaborative Study Group"], "date": "2001-05-01T00:00:00Z", "doi": "10.1093/ndt/16.5.961", "meta_date_publication": "2001 May", "meta_volume": "16", "meta_issue": "5", "meta_pages": "961-6", "score": 50074.547, "text_hl": "Effect of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ on the progression of @DISEASE_Renal_Insufficiency @DISEASE_MESH:D051437 @@@renal insufficiency@@@ in mild proteinuric @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@non-diabetic nephropathies@@@.", "citations": {"NLM": "Cinotti GA, Zucchelli PC, Collaborative Study Group. Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies. Nephrol Dial Transplant. 2001 May;16(5):961-6. PMID: 11328901", "BibTeX": "@article{11328901, title={Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies.}, author={Cinotti GA and Zucchelli PC and Collaborative Study Group}, journal={Nephrol Dial Transplant}, volume={16}, number={5}, pages={961-6}}"}}, {"_id": "9279969", "pmid": 9279969, "title": "Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.", "journal": "Scand J Clin Lab Invest", "authors": ["Nielsen FS", "Rossing P", "Gall MA", "Smidt UM", "Chen JW", "Sato A", "Parving HH"], "date": "1997-08-01T00:00:00Z", "doi": "10.3109/00365519709084591", "meta_date_publication": "1997 Aug", "meta_volume": "57", "meta_issue": "5", "meta_pages": "427-34", "score": 50073.31, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ improves @DISEASE_Vascular_Diseases @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@hypertensive NIDDM@@@ subjects with @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@.", "citations": {"NLM": "Nielsen FS, Rossing P, Gall MA, Smidt UM, Chen JW, Sato A, Parving HH. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy. Scand J Clin Lab Invest. 1997 Aug;57(5):427-34. PMID: 9279969", "BibTeX": "@article{9279969, title={Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.}, author={Nielsen FS and Rossing P and Gall MA and Smidt UM and Chen JW and Sato A and Parving HH}, journal={Scand J Clin Lab Invest}, volume={57}, number={5}, pages={427-34}}"}}]}